Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.

PURPOSE: Our objective was to develop a system to simultaneously and quantitatively measure the expression levels of the insulin-like growth factor (IGF) family proteins in numerous samples and to apply this approach to profile the IGF family proteins levels in cancer and adjacent tissues from patie...

Full description

Bibliographic Details
Main Authors: Qi Zhou, Ying-Qing Mao, Wei-Dong Jiang, Yun-Ru Chen, Ren-Yu Huang, Xiang-Bing Zhou, Ya-Feng Wang, Zhi Shi, Zhong-Sheng Wang, Ruo-Pan Huang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3469629?pdf=render
_version_ 1819021677316538368
author Qi Zhou
Ying-Qing Mao
Wei-Dong Jiang
Yun-Ru Chen
Ren-Yu Huang
Xiang-Bing Zhou
Ya-Feng Wang
Zhi Shi
Zhong-Sheng Wang
Ruo-Pan Huang
author_facet Qi Zhou
Ying-Qing Mao
Wei-Dong Jiang
Yun-Ru Chen
Ren-Yu Huang
Xiang-Bing Zhou
Ya-Feng Wang
Zhi Shi
Zhong-Sheng Wang
Ruo-Pan Huang
author_sort Qi Zhou
collection DOAJ
description PURPOSE: Our objective was to develop a system to simultaneously and quantitatively measure the expression levels of the insulin-like growth factor (IGF) family proteins in numerous samples and to apply this approach to profile the IGF family proteins levels in cancer and adjacent tissues from patients with hepatocellular carcinoma (HCC). EXPERIMENTAL DESIGN: Antibodies against ten IGF family proteins (IGF-1, IGF-1R, IGF-2, IGF-2R, IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IGFBP-6, and Insulin) were immobilized on the surface of a glass slide in an array format to create an IGF signaling antibody array. Tissue lysates prepared from patient's liver cancer tissues and adjacent tissues were then applied to the arrays. The proteins captured by antibodies on the arrays were then incubated with a cocktail of biotinylated detection antibodies and visualized with a fluorescence detection system. By comparison with standard protein amount, the exact protein concentrations in the samples can be determined. The expression levels of the ten IGF family proteins in 25 pairs of HCC and adjacent tissues were quantitatively measured using this novel antibody array technology. The differential expression levels between cancer tissues and adjacent tissues were statistically analyzed. RESULTS: A novel IGF signaling antibody array was developed which allows the researcher to simultaneously detect ten proteins involved in IGF signal pathway with high sensitivity and specificity. Using this approach, we found that the levels of IGF-2R and IGFBP-2 in HCC tissues were higher than those in adjacent tissues. CONCLUSION: Our IGF signaling antibody array which can detect the expression of ten IGF family members with high sensitivity and specificity will undoubtedly prove a powerful tool for drug and biomarker discovery.
first_indexed 2024-12-21T04:10:54Z
format Article
id doaj.art-c93ad34cc7e84fe3b1aa42c4ea93b36e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T04:10:54Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c93ad34cc7e84fe3b1aa42c4ea93b36e2022-12-21T19:16:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01710e4685110.1371/journal.pone.0046851Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.Qi ZhouYing-Qing MaoWei-Dong JiangYun-Ru ChenRen-Yu HuangXiang-Bing ZhouYa-Feng WangZhi ShiZhong-Sheng WangRuo-Pan HuangPURPOSE: Our objective was to develop a system to simultaneously and quantitatively measure the expression levels of the insulin-like growth factor (IGF) family proteins in numerous samples and to apply this approach to profile the IGF family proteins levels in cancer and adjacent tissues from patients with hepatocellular carcinoma (HCC). EXPERIMENTAL DESIGN: Antibodies against ten IGF family proteins (IGF-1, IGF-1R, IGF-2, IGF-2R, IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-4, IGFBP-6, and Insulin) were immobilized on the surface of a glass slide in an array format to create an IGF signaling antibody array. Tissue lysates prepared from patient's liver cancer tissues and adjacent tissues were then applied to the arrays. The proteins captured by antibodies on the arrays were then incubated with a cocktail of biotinylated detection antibodies and visualized with a fluorescence detection system. By comparison with standard protein amount, the exact protein concentrations in the samples can be determined. The expression levels of the ten IGF family proteins in 25 pairs of HCC and adjacent tissues were quantitatively measured using this novel antibody array technology. The differential expression levels between cancer tissues and adjacent tissues were statistically analyzed. RESULTS: A novel IGF signaling antibody array was developed which allows the researcher to simultaneously detect ten proteins involved in IGF signal pathway with high sensitivity and specificity. Using this approach, we found that the levels of IGF-2R and IGFBP-2 in HCC tissues were higher than those in adjacent tissues. CONCLUSION: Our IGF signaling antibody array which can detect the expression of ten IGF family members with high sensitivity and specificity will undoubtedly prove a powerful tool for drug and biomarker discovery.http://europepmc.org/articles/PMC3469629?pdf=render
spellingShingle Qi Zhou
Ying-Qing Mao
Wei-Dong Jiang
Yun-Ru Chen
Ren-Yu Huang
Xiang-Bing Zhou
Ya-Feng Wang
Zhi Shi
Zhong-Sheng Wang
Ruo-Pan Huang
Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.
PLoS ONE
title Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.
title_full Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.
title_fullStr Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.
title_full_unstemmed Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.
title_short Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers.
title_sort development of igf signaling antibody arrays for the identification of hepatocellular carcinoma biomarkers
url http://europepmc.org/articles/PMC3469629?pdf=render
work_keys_str_mv AT qizhou developmentofigfsignalingantibodyarraysfortheidentificationofhepatocellularcarcinomabiomarkers
AT yingqingmao developmentofigfsignalingantibodyarraysfortheidentificationofhepatocellularcarcinomabiomarkers
AT weidongjiang developmentofigfsignalingantibodyarraysfortheidentificationofhepatocellularcarcinomabiomarkers
AT yunruchen developmentofigfsignalingantibodyarraysfortheidentificationofhepatocellularcarcinomabiomarkers
AT renyuhuang developmentofigfsignalingantibodyarraysfortheidentificationofhepatocellularcarcinomabiomarkers
AT xiangbingzhou developmentofigfsignalingantibodyarraysfortheidentificationofhepatocellularcarcinomabiomarkers
AT yafengwang developmentofigfsignalingantibodyarraysfortheidentificationofhepatocellularcarcinomabiomarkers
AT zhishi developmentofigfsignalingantibodyarraysfortheidentificationofhepatocellularcarcinomabiomarkers
AT zhongshengwang developmentofigfsignalingantibodyarraysfortheidentificationofhepatocellularcarcinomabiomarkers
AT ruopanhuang developmentofigfsignalingantibodyarraysfortheidentificationofhepatocellularcarcinomabiomarkers